Related references
Note: Only part of the references are listed.Chronic intranasal deferoxamine ameliorates motor defects and pathology in the α-synuclein rAAV Parkinson's model
Fabia Febbraro et al.
EXPERIMENTAL NEUROLOGY (2013)
X-ray fluorescence analysis of iron and manganese distribution in primary dopaminergic neurons
Tanja Ducic et al.
JOURNAL OF NEUROCHEMISTRY (2013)
Pramipexole in patients with early Parkinson's disease (PROUD): a randomised delayed-start trial
Anthony H. V. Schapira et al.
LANCET NEUROLOGY (2013)
Iron metabolism in the CNS: implications for neurodegenerative diseases
Tracey A. Rouault
NATURE REVIEWS NEUROSCIENCE (2013)
Targeting Mitochondria for Neuroprotection in Parkinson's Disease
Anthony Henry Vernon Schapira
ANTIOXIDANTS & REDOX SIGNALING (2012)
Chelating Agents for the Treatment of Systemic Iron Overload
Y. Ma et al.
CURRENT MEDICINAL CHEMISTRY (2012)
Does structural neuroimaging reveal a disturbance of iron metabolism in Parkinson's disease? Implications from MRI and TCS studies
Adriane Groeger et al.
JOURNAL OF NEURAL TRANSMISSION (2012)
Iron Overload in Human Disease
Robert E. Fleming et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Differential susceptibility to the PPAR-γ agonist pioglitazone in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 6-hydroxydopamine rodent models of Parkinson's disease
C. Laloux et al.
PHARMACOLOGICAL RESEARCH (2012)
Identification of nonferritin mitochondrial iron deposits in a mouse model of Friedreich ataxia
Megan Whitnall et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
NMR spectroscopy metabolomic profiling of exhaled breath condensate in patients with stable and unstable cystic fibrosis
Paolo Montuschi et al.
THORAX (2012)
Mitochondrial Mayhem: The Mitochondrion as a Modulator of Iron Metabolism and Its Role in Disease
Michael Li-Hsuan Huang et al.
ANTIOXIDANTS & REDOX SIGNALING (2011)
Profile of altered brain iron acquisition in restless legs syndrome
James R. Connor et al.
BRAIN (2011)
Rescuing iron-overloaded macrophages by conservative relocation of the accumulated metal
Yang-Sung Sohn et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Combined Therapy with Idebenone and Deferiprone in Patients with Friedreich's Ataxia
Daniel Velasco-Sanchez et al.
CEREBELLUM (2011)
Oxidation Chemistry of Catecholamines and Neuronal Degeneration: An Update
A. Napolitano et al.
CURRENT MEDICINAL CHEMISTRY (2011)
The Mitochondrial Dynamics of Alzheimers Disease and Parkinsons Disease Offer Important Opportunities for Therapeutic Intervention
David J. Bonda et al.
CURRENT PHARMACEUTICAL DESIGN (2011)
H-ferritin is the Major Source of Iron for Oligodendrocytes
Bozho Todorich et al.
GLIA (2011)
A pilot trial of deferiprone for neurodegeneration with brain iron accumulation
Giovanni Abbruzzese et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Iron chelation and neuroprotection in neurodegenerative diseases
Xuping Li et al.
JOURNAL OF NEURAL TRANSMISSION (2011)
Clinically available iron chelators induce neuroprotection in the 6-OHDA model of Parkinson's disease after peripheral administration
David T. Dexter et al.
JOURNAL OF NEURAL TRANSMISSION (2011)
Rapid, complete and large-scale generation of post-mitotic neurons from the human LUHMES cell line
Diana Scholz et al.
JOURNAL OF NEUROCHEMISTRY (2011)
A double-blind, delayed-start trial of rasagiline in Parkinson's disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomes
Olivier Rascol et al.
LANCET NEUROLOGY (2011)
Combined R2*and Diffusion Tensor Imaging Changes in the Substantia Nigra in Parkinson's Disease
Guangwei Du et al.
MOVEMENT DISORDERS (2011)
The potential application of iron chelators for the treatment of neurodegenerative diseases
Robert C. Hider et al.
METALLOMICS (2011)
On improvement in ejection fraction with iron chelation in thalassemia major and the risk of future heart failure
D. J. Pennell et al.
JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE (2011)
Neuroprotective Multifunctional Iron Chelators: From Redox-Sensitive Process to Novel Therapeutic Opportunities
Orly Weinreb et al.
ANTIOXIDANTS & REDOX SIGNALING (2010)
Iron Regulatory Proteins: From Molecular Mechanisms to Drug Development
Stefania Recalcati et al.
ANTIOXIDANTS & REDOX SIGNALING (2010)
Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature
Patrice Peran et al.
BRAIN (2010)
Iron redistribution as a therapeutic strategy for treating diseases of localized iron accumulation
Or Kakhlon et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2010)
Mitochondrial Iron Metabolism and Its Role in Neurodegeneration
Maxx P. Horowitz et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Study of brain anatomy with high-field MRI: recent progress
Jozef H. Duyn
MAGNETIC RESONANCE IMAGING (2010)
Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1
Jaime N. Guzman et al.
NATURE (2010)
Deferiprone Chelation Therapy for Thalassemia Major
R. Galanello et al.
ACTA HAEMATOLOGICA (2009)
Glutathione-a review on its role and significance in Parkinson's disease
Heather L. Martin et al.
FASEB JOURNAL (2009)
Inhibition of Prolyl Hydroxylase Protects against 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Neurotoxicity MODEL FOR THE POTENTIAL INVOLVEMENT OF THE HYPOXIA-INDUCIBLE FACTOR PATHWAY IN PARKINSON DISEASE
Donna W. Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Increased oxidative damage in peripheral blood correlates with severity of Parkinson's disease
Chiung-Mei Chen et al.
NEUROBIOLOGY OF DISEASE (2009)
Anemia or low hemoglobin levels preceding Parkinson disease A case-control study
R. Savica et al.
NEUROLOGY (2009)
A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease
C. Warren Olanow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Intracellular labile iron
William Breuer et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2008)
MRI Assessment of Basal Ganglia Iron Deposition in Parkinson's Disease
Lauren I. Wallis et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2008)
Neuroprotective actions of deferiprone in cultured cortical neurones and SHSY-5Y cells
Francisco Molina-Holgado et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Regulation of iron acquisition and storage: consequences for iron-linked disorders
Ivana De Domenico et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
Redistribution of accumulated cell iron: a modality of chelation with therapeutic implications
Yang-Sung Sohn et al.
BLOOD (2008)
Non-transferrin-bound iron reaches mitochondria by a chelator-inaccessible mechanism: biological and clinical implications
Maya Shvartsman et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2007)
Selective iron chelation in Friedreich ataxia:: biologic and clinical implications
Nathalie Boddaert et al.
BLOOD (2007)
Biomonitoring of the adverse effects induced by the chronic exposure to lead and cadmium on kidney function:: Usefulness of alpha-glutathione S-transferase
Guillaume Garcon et al.
SCIENCE OF THE TOTAL ENVIRONMENT (2007)
Magnetic resonance imaging measurement of iron overload
John C. Wood
CURRENT OPINION IN HEMATOLOGY (2007)
Dunkerque City air pollution particulate matter-induced cytotoxicity, oxidative stress and inflammation in human epithelial lung cells (L 132) in culture
Guillaume Garcon et al.
TOXICOLOGY IN VITRO (2006)
Timing of treatment initiation in Parkinson's disease: A need for reappraisal?
AHV Schapira et al.
ANNALS OF NEUROLOGY (2006)
Oxidative stress and neurodegeneration: where are we now?
Barry Halliwell
JOURNAL OF NEUROCHEMISTRY (2006)
Intracellular labile iron pools as direct targets of iron chelators: a fluorescence study of chelator action in living cells
H Glickstein et al.
BLOOD (2005)
Increased sensitivity of striatal dopamine release to H2O2 upon chronic rotenone treatment
E Milusheva et al.
FREE RADICAL BIOLOGY AND MEDICINE (2005)
Design, synthesis, and evaluation of novel bifunctional iron-chelators as potential agents for neuroprotection in Alzheimer's, Parkinson's, and other neurodegenerative diseases
HL Zheng et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2005)
High-performance liquid chromatography/tandem mass spectrometry assay for the determination of 1-methyl-4-phenyl pyridinium (MPP+) in brain tissue homogenates
MEP Hows et al.
JOURNAL OF NEUROSCIENCE METHODS (2004)
Iron, brain ageing and neurodegenerative disorders
L Zecca et al.
NATURE REVIEWS NEUROSCIENCE (2004)
Relaxation induced by ferritin: a better understanding for an improved MRI iron quantification
Y Gossuin et al.
NMR IN BIOMEDICINE (2004)
Safety and effectiveness of long-term therapy with the oral iron chelator deferiprone
AR Cohen et al.
BLOOD (2003)
Iron misregulation in the brain: a primary cause of neurodegenerative disorders
Y Ke et al.
LANCET NEUROLOGY (2003)
Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: A novel therapy for Parkinson's disease
D Kaur et al.
NEURON (2003)
Iron metabolism and mitochondrial abnormalities in Friedreich ataxia
M Pandolfo
BLOOD CELLS MOLECULES AND DISEASES (2002)
A review of fluorescence methods for assessing labile iron in cells and biological fluids
BP Espósito et al.
ANALYTICAL BIOCHEMISTRY (2002)
Modulation of somatodendritic dopamine release by endogenous H2O2:: Susceptibility in substantia nigra but resistance in VTA
BT Chen et al.
JOURNAL OF NEUROPHYSIOLOGY (2002)
Polycyclic aromatic hydrocarbon coated onto Fe2O3 particles:: assessment of cellular membrane damage and antioxidant system disruption in human epithelial lung cells (L132) in culture
G Garçon et al.
TOXICOLOGY LETTERS (2000)
Share Paper
